Jim Datin is Highlighted in TBJ Talking About BioAgilytix’ Performance in 2020 and Beyond
In this news article, our CEO Jim Datin discusses with Triangle Business Journal about BioAgilytix’ performance and the challenges they have experienced in 2020.
Share This